Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Recruiting2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT06167460Recruiting
Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.
Non Small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IIIC Non-Small Cell Lung Cancer+2 more
PrincipalinvestigatorStart date: 2023-12-04
NCT06087120Recruiting
Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
Breast Cancer FemaleHER2-positive Breast CancerStage II Breast Cancer+2 more
PrincipalinvestigatorStart date: 2023-09-16

Research Network

Collaboration Network

3 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Trung Q Lam, MD

University medical center HCMC

Similar
1 trials

Shared therapeutic areas:

Breast Cancer FemaleHER2-positive Breast CancerStage II Breast Cancer+2 more

Worked with same sponsors:

Gene Solutions
Collaborated on 1 trial
Similarity Score54%

Samuel J Haryono, MD

MRCCC Siloam Hospitals Semanggi

Similar
1 trials

Shared therapeutic areas:

Breast Cancer FemaleHER2-positive Breast CancerStage II Breast Cancer+2 more

Worked with same sponsors:

Gene Solutions
Collaborated on 1 trial
Similarity Score54%

Project Leader

Ono Pharmaceutical Co., Ltd.

Related
47 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungStage IIIB Non-small Cell Lung CancerStage IIIC Non-Small Cell Lung Cancer+1 more
Similarity Score12%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungTriple Negative Breast Neoplasms
Similarity Score6%

Norman Wolmark, MD

NSABP Foundation Inc

Related
54 trials

Shared therapeutic areas:

Stage II Breast CancerTriple Negative Breast Neoplasms
Similarity Score6%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score3%

Toshimitsu Tokimoto

Astrazeneca KK

Related
16 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score3%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score3%

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Related
19 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score3%

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell Lung
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06167460PrincipalInvestigator

Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC.

Non Small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IIIC Non-Small Cell Lung Cancer+2 more
Recruiting
NCT06087120PrincipalInvestigator

Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment

Breast Cancer FemaleHER2-positive Breast CancerStage II Breast Cancer+2 more
Recruiting

All 2 trials loaded